Loading organizations...
Loading organizations...
Develops allergy vaccines for ultra-fast desensitization.
Anergis has raised $19.5M across 1 funding round.
Anergis has raised $19.5M in total across 1 funding round.
Anergis has raised $19.5M in total across 1 funding round.
Anergis's investors include BioMedPartners, Sten Verland, Patrick Scherrer.
Anergis has raised $19.5M across 1 funding round. Most recently, it raised $19.5M Series A in March 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 30, 2011 | $19.5M Series A | BioMedPartners, Sten Verland, Patrick Scherrer |